First Hawaiian Bank’s Myriad Genetics MYGN Stock Holding History

First Hawaiian Bank’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-91	Closed	-$3K	–	1240
2019 Q1	$3K	Hold	91	–	–	﹤0.01%	1595
2018 Q4	$3K	Sell	91 -315	-78%	-$11.3K	﹤0.01%	1684
2018 Q3	$18K	Buy	+406	New	+$18.1K	﹤0.01%	1394

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Hawaiian Bank's MYGN Position: Q2 2019 in Review

First Hawaiian Bank sold out of Myriad Genetics (MYGN) in Q2 2019, closing a stake of 91 shares — an estimated $3K sold.

First Hawaiian Bank first reported a position in MYGN in Q3 2018 and held it in 3 quarters. The position peaked at $18K in Q3 2018. 235 funds tracked by Wall St. Rank hold MYGN as of Q2 2019.

First Hawaiian Bank reported no remaining Myriad Genetics position as of Q2 2019 after selling out during the quarter.
First Hawaiian Bank sold 91 Myriad Genetics shares in Q2 2019, an estimated $3K.
First Hawaiian Bank first reported a position in Myriad Genetics in Q3 2018 and held it in 3 quarters.
First Hawaiian Bank's Myriad Genetics position peaked at $18K in Q3 2018.
235 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.